Yes, they took it to phase2 trials and then they prioritized oxycodone over morphine in Sept 2007 because Harry Rosen said
"Harry Rosen, Phosphagenics' President and CEO, said: "We have prioritized oxycodone over morphine in our pain management pipeline as we are in commercial discussions with several companies.
http://www.prnewswire.com/news-releases/phosphagenics-to-conduct-a-phase-1-transdermal-oxycodone-clinical-trial-58078492.html
Ann: Phosphagenics Pain Program Update , page-38
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.507M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $1.891K | 630.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 14261342 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 17374189 | 11 |
View Market Depth
| Last trade - 16.10pm 24/01/2025 (20 minute delay) ? |
| AVE (ASX) Chart |